Cancer chemotherapy and biotherapy : principles and practice /
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | , |
Formato: | Libro |
Idioma: | Inglés |
Publicado: |
Philadelphia :
Lippincott Williams & Wilkins,
c2006.
|
Edición: | 4th ed. |
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Delivering anticancer drugs to brain tumors / Maciej M. Mrugala, Tracy T. Batchelor, Jeffrey G. Supko
- Food and drug administration role in oncology product development / Thomas G. Roberts Jr.
- Central venous catheters: care and complications / Rachel P. Rosovsky, David J. Kuter
- Pharmacogenetics / Jeanne Fourie, Robert B. Diasio
- New targets for anticancer therapeutics / A. Dimitrios Colevas ... [et al.]
- Bisphosphonates / Matthew R. Smith
- Thalidomide and its analogs for the treatment of hematologic malignancies, including multiple myeloma, and solid tumors / Paul Richardson ... [et al.]
- Inhibitors of tumor angiogenesis / Anaadriana Zakarija, William J. Gradishar
- Proteasome inhibitors / Owen A. O'Connor
- Molecular targeted drugs and growth factor receptor inhibitors / Jeffrey W. Clark
- Antibody therapies of cancer / David A. Scheinberg ... [et al.]
- Interferons / Daniel J. Lindner ... [et al.]
- Adoptive cellular therapies / Carl H. June
- Cancer vaccines / Glenn Dranoff
- Hematopoietic growth factors / William P. Petros
- Interleukins / Gheath Alatrash ... [et al.]
- Harmonal therapy for breast cancer / Peter F. Lebowitz, Sandra M. Swain.
- Clinical strategies for cancer treatment: the role of drugs / Bruce Chabner
- Preclinical aspects of cancer drug discovery and development / Paula Krosky ... [et al.]
- Pharmacokinetics / Jerry Collins, Jeffrey G. Supko
- Infertility after cancer chemotherapy / Angela Bradbury, Richard L. Schilsky
- Carcinogenesis of anticancer drugs / Laawrence S. Blaszkowsky, Charles Erlichman
- Antifolates / Brian P. Monahan, Carmen J. Allegra
- 5-Fluoropyrimidine / Jean L. Grem
- Cytidine analogues / David P. Ryan, Rocio Garcia-Carbonero, Bruce A. Chabner
- Purine antimetabolites / Kenneth R. Hande
- Hydroxyurea / Luis Paz-Ares, Ross C. Donehower, Bruce A. Chabner
- Antimicrotubule agents / Eric K. Rowinsky
- Clinical and high-dose alkylating agents / Kenneth D. Tew, O. Michael Colvin, Roy B. Jones
- Nonclassic agents / Henry S. Friedman, Steven D. Averbuch, Joanne Kurtzberg
- Cisplatin, Carboplatin, and oxaliplatin / Eddie Reed
- Bleomycin / John s. Lazo, Bruce A. Chabner
- Antitumor antibiotics / Edwin W. Willems, Kees Nooter, Jaap Verweij
- Topoisomerase I-targeting drugs / Alex Sparreboom, William C. Zamboni
- Anthracyclines and anthracenediones / James H. Doroshow
- Topoisomerase II inhibitors: the epipodophyllotoxins, acridines, and ellipticines / Yves Pommier, François Goldwasser
- Asparaginase / Bruce A. Chabner, Alison M. Friedmann
- Clinical strategies / Bruce Chabner
- Preclinical aspects of cancer drug discovery / Ed Sausville ... [et al.]
- Pharmacokinetics / Jerry Collins
- Infertility / Angela Bradbury, Richard Schilsky
- Carcinogenesis / Larry Blaszkowsky
- Antifolates / Carmen Allegra, Brian Monahan
- 5 fluoropyrimidine / Jean Grem
- Cytidine analogues / David Ryan
- Purine analogues / Kenneth Hande
- Hydroxyurea / Bruce Chabner
- Antimicrotuble agents / Eric Rowinsky
- Alkylating agents/clinical & high dose / Roy Jones, Ken Tew
- Nonclassical agents / Henry Friedman
- Platinum analogues / Ed Reed
- Bleomycin / Bruce Chabner
- Antibiotics / Kees Nooter, Jaap Verweij, Edwin Willems
- Topo I: inhibitors / Alex Sparreboom, William Zamboni
- Topo II: anthracyclines / Jim Doroshow
- Topo II: epipodophylotoxins / Yves Pommier, Francios Goldwasser
- L-asparaginase / Bruce Chabner
- Pharmacology of CNS agents / Jeff Supko
- FDA approval / Thomas Roberts
- Catheter and complications / David Kuter, Rachel Rosovsky
- Pharmacogenetics / Robert Diasio, Jeanne Fourie
- New agents / Louise Grochow
- Bisphosphonates / Matthew Smith
- Thalidomide / Paul Richardson
- Inhibitors of tumor angiogenesis / William Gradishar, Anaadriana Zakarija
- Proteosome inhibitors / Owen O'Connor
- Molecular targeted drugs-growth factor receptor inhibitors / Jeff Clark
- Monoclonal antibody therapies / David Scheinberg
- Interferon / Danield Linder, Earnest Borden
- Adoptive therapies / Carl June
- Vaccines / Glenn Dranoff
- Hematopoietic growth factors / William Petros
- Interleukins / Gheath Alatrash ... [et al.]
- Hormonal therapy for breast cancer and prostate / Peter Lebowitz, Sandra Swain, Steven Balk.